Treatment of Chronic Hepatitis With Sofosbuvir in Combination With Ribavirin With or Without Pegylated Interferon: North India Gastroenterology Consortium

Trial Profile

Treatment of Chronic Hepatitis With Sofosbuvir in Combination With Ribavirin With or Without Pegylated Interferon: North India Gastroenterology Consortium

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Oct 2016

At a glance

  • Drugs Sofosbuvir (Primary) ; Peginterferon alfa-2a; Ribavirin
  • Indications Hepatitis
  • Focus Therapeutic Use
  • Acronyms GCNI-CHC
  • Most Recent Events

    • 24 Sep 2016 Status changed from active, no longer recruiting to completed.
    • 08 Sep 2016 Planned End Date changed from 1 Aug 2016 to 1 Sep 2016.
    • 08 Sep 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Sep 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top